175 related articles for article (PubMed ID: 7349893)
1. Ultrastructral changes induced by 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea in L1210 lymphocytic leukemia cells in mice.
Fukuda K; Shindo H; Shimizu F; Arakawa M; Mizuhira V
Cancer Res; 1980 Jan; 40(1):133-8. PubMed ID: 7349893
[TBL] [Abstract][Full Text] [Related]
2. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
[TBL] [Abstract][Full Text] [Related]
3. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
4. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic synergism elicited by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride: synergistic cytocidal activity against L1210 cells in vitro.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):659-66. PubMed ID: 6939645
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
Nagourney RA; Fox P; Schein PS
Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
[TBL] [Abstract][Full Text] [Related]
7. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
8. Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.
Shimizu F; Arakawa M
Gan; 1975 Apr; 66(2):149-54. PubMed ID: 1150007
[TBL] [Abstract][Full Text] [Related]
9. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD
Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
Gugova RG; Raikov ZD; Zakhariev SG; Demirov GD; Todorov DK; Ilarionova MV
Drugs Exp Clin Res; 1989; 15(10):497-500. PubMed ID: 2632217
[TBL] [Abstract][Full Text] [Related]
11. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
13. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA
Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736
[TBL] [Abstract][Full Text] [Related]
14. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.
Yamada K; Ushio Y; Hayakawa T; Arita N; Huang TY; Nagatani M; Yamada N; Mogami H
Cancer Res; 1987 Apr; 47(8):2123-8. PubMed ID: 3470138
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
16. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
[TBL] [Abstract][Full Text] [Related]
17. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
[TBL] [Abstract][Full Text] [Related]
18. [Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea].
Durdyeva ED; Kukushkina GV; Gorbacheva KB
Biull Eksp Biol Med; 1986 Feb; 101(2):192-5. PubMed ID: 3947737
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
